Stocks to sell

At one point, Zomedica (NYSE:ZOM) could do no wrong. ZOM stock would explode some 2,900% from its November 2020 lows. The company was nearing commercialization of its point-of-care diagnostic product. Even the pet industry was howling about the opportunity. Source: Postmodern Studio / Nowadays, Zomedica has become a slow-motion train wreck. In fact, the last
Movie theater chain AMC Entertainment (NYSE:AMC) has had a busy few weeks. First, the Reddit favorite abandoned its request that its shareholders approve the issuance of 25 million new shares. Then, AMC announced that CEO Adam Aron would also become its chairman, replacing an executive at billionaire-controlled Dalian Wanda Group. Both of these news items
Meta Materials (NASDAQ:MMAT) is a Canadian company that recently listed on the Nasdaq via a SPAC (special purpose acquisition corporation) reverse merger. To put it bluntly, MMAT stock is the kind of highly speculative stock you ought to avoid. Source: Shutterstock This high-tech company develops nanocomposite materials and products. The debt-free company announced it had closed
In a matter of weeks, DiDi Global (NYSE:DIDI) stock has gone from a hot IPO to an undeniable disaster. Soon after its debut on the U.S. stock market at an initial price of $14 per share, the China-based ride-hailing company was hit hard by the  Chinese government’s decision to investigate and penalize it. The shares
Other than a short-lived rally in June fueled by Reddit users, ContextLogic (NASDAQ:WISH) stock is on a permanent trajectory downward. Source: sdx15 / WISH stock peaked at $32.85, shortly after its initial public offering earlier this year. The company’s unfavorable valuations, mixed first-quarter results, and poor sales forecast continue to weigh on its share
A decade ago, after returning to finance from 30 years covering computer technology, I got into an argument over a company called Dendreon. You’ll see why this lingering thoughts connects me to BIIB stock below. Source: PictureDesignSwiss / Dendreon had launched a treatment for prostate cancer called Provenge. It is an immunotherapy, tied to
GameStop (NYSE:GME) stock has been one of 2021’s most incredible investing stories. The initial short squeeze was incredible to watch. Few market analysts could have ever imagined that a struggling mall retailer like GameStop could see its shares surge thousands of percent. Source: rblfmr / That surge, in turn, saved the company. GameStop raised
A deep dive into SoFi Technologies (NASDAQ:SOFI) stock provides reason enough not to get on board. Those fundamentals will provide the backbone of my argument against investing in SoFi.  Source: rafapress / I would argue that potential investors avoid the buzz and buzzwords around the SPAC gone public financial services company. Specifically, I’d urge investors,